Volume 20 Issue 7
Jul.  2022
Turn off MathJax
Article Contents
ZHANG Fang, CHEN Guo-fan, WANG Ming-wei, REN Kai-han. Correlation between plasma homocysteine and blood pressure variability in patients with coronary heart disease complicated with hypertension[J]. Chinese Journal of General Practice, 2022, 20(7): 1106-1108. doi: 10.16766/j.cnki.issn.1674-4152.002534
Citation: ZHANG Fang, CHEN Guo-fan, WANG Ming-wei, REN Kai-han. Correlation between plasma homocysteine and blood pressure variability in patients with coronary heart disease complicated with hypertension[J]. Chinese Journal of General Practice, 2022, 20(7): 1106-1108. doi: 10.16766/j.cnki.issn.1674-4152.002534

Correlation between plasma homocysteine and blood pressure variability in patients with coronary heart disease complicated with hypertension

doi: 10.16766/j.cnki.issn.1674-4152.002534
Funds:

 2021KY890

  • Received Date: 2021-11-12
    Available Online: 2022-09-23
  •   Objective  To investigate the correlation between plasma homocysteine (Hcy) and blood pressure variability (BPV) in patients with coronary heart disease (CHD) complicated with hypertension.  Methods  A total of 146 cases of patients with CHD with high blood pressure from February 2019 to June 2020 in the hospital treatment were selected. In accordance with high Hcy, they were divided into observation group (78 cases, Hcy≥10 mmol/L) and control group (68 cases, Hcy levels < 10 mmol/L). The related clinical data of the two groups were compared. The correlation between plasma Hcy levels and BPV was analysed.  Results  Uric acid (UA), total cholesterol (TC), fasting blood glucose, Hcy, 24-h systolic blood pressure (24-h SBP), 24-h diastolic blood pressure (24-h DBP), 24-h systolic blood pressure variation (24-h SPV) and 24-h diastolic blood pressure variation (24-h DPV) in the observation group were significantly higher than in the control group (t=23.379, 4.233, 2.632, 111.075, 4.254, 9.452, 20.989 and 8.631, respectively; all P < 0.01). Pearson correlation analysis showed that UA, Hcy and TC were correlated with 24 h SBP, 24 h DBP and 24-h SPV, respectively, whilst DPV was positively correlated (r=0.349, 0.286, 0.413, 0.351, 0.507, 0.512, 0.518, 0.568, 0.326, 0.198, 0.348, 0.192, all P < 0.05). The results of multiple linear regression analysis showed that the influence of UA and TC on BPV index was adjusted Hcy level was positively correlated with 24 h SBP (β=0.023, P=0.029), 24-h DBP (β=0.028, P=0.034), 24-h SPV (β=0.156, P=0.005) and 24-h DPV (β=0.035, P=0.039).  Conclusion  A positive correlation existed between Hcy and BPV in patients with CHD complicated with hypertension. Hcy and BPV may interact with each other in promoting the occurrence and development of CHD. The changes of Hcy and BPV in these patients should be closely monitored clinically and the levels of Hcy and BPV should be actively controlled to improve the prevention and treatment effect of CHD.

     

  • loading
  • [1]
    刘玮. 冠心病患者血尿酸及同型半胱氨酸水平与冠状动脉病变程度的关系及意义分析[J]. 中外医学研究, 2018, 16(8): 44-45. https://www.cnki.com.cn/Article/CJFDTOTAL-YJZY201808021.htm

    LIU W. Analysis of significance and correlation between serum uric acid, homocysteine and the severity of coronary artery disease in patients with coronary heart disease[J]. Chinese And Foreign Medical Research, 2018, 16(8): 44-45. https://www.cnki.com.cn/Article/CJFDTOTAL-YJZY201808021.htm
    [2]
    蒯琳, 洪梅. 血清同型半胱氨酸、高敏C反应蛋白、胱抑素C水平与冠状动脉粥样硬化的关系[J]. 中国医药导报, 2018, 15(35): 58-61. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201835014.htm

    KUAI L, HONG M. Connection of homocysteine, high sensitivity C-reactive protein and cystatin C with coronary atherosclerosis[J]. China Medical Herald, 2018, 15(35): 58-61. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201835014.htm
    [3]
    段平, 尹德录. 高同型半胱氨酸代谢酶基因多态性与冠心病发病关系的研究进展[J]. 中国循证心血管医学杂志, 2017, 9(2): 249-251. https://www.cnki.com.cn/Article/CJFDTOTAL-PZXX201702039.htm

    DUAN P YIN D L. Research progress on the relationship between genetic polymorphisms of homocysteine metabolizing enzyme and onset of coronary heart disease[J]. Chinese Journal of Evidence-based Cardiovascular Medicine, 2017, 9(2): 249-251. https://www.cnki.com.cn/Article/CJFDTOTAL-PZXX201702039.htm
    [4]
    汪浩伟, 文美, 杨建昌. 血压变异性与冠状动脉病变程度相关性分析[J]. 贵州医药, 2016, 40(8): 840-842. https://www.cnki.com.cn/Article/CJFDTOTAL-GZYI201608019.htm

    WANG H W, WEN M, YANG J C. Correlation between blood pressure variability and severity of coronary artery disease[J]. Guizhou Medical Journal, 2016, 40(8): 840-842. https://www.cnki.com.cn/Article/CJFDTOTAL-GZYI201608019.htm
    [5]
    LI S H, ZHU J M, WU L, et al. The association between plasma homocysteine and ambulatory blood pressure variability in patients with untreated hypertension[J]. Clin Chim Acta, 2018. DOI: 10.1016/j.cca.2017.11.042.
    [6]
    《中国高血压防治指南》修订委员会. 中国高血压防治指南2018年修订版[J]. 心脑血管病防治, 2019, 19(1): 1-44. https://www.cnki.com.cn/Article/CJFDTOTAL-XIXG201901003.htm

    Writing group of 2018 Chinese guidelines for the management of hypertension. 2018 Chinese guidelines for the management of hypertension[J]. Chinese Journal of Cardiovascular Medicine, 2019, 19(1): 1-44. https://www.cnki.com.cn/Article/CJFDTOTAL-XIXG201901003.htm
    [7]
    ABRAHAM W T, STEVENSON L W, BOURGE R C, et al. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: Complete follow-up results from the CHAMPION randomised trial[J]. Lancet, 2016, 387(10017): 453-461. doi: 10.1016/S0140-6736(15)00723-0
    [8]
    曹明, 王奇军. H型高血压患者血浆同型半胱氨酸水平变化对动脉粥样硬化性疾病的影响[J]. 检验医学, 2019, 34(11): 1007-1010. https://www.cnki.com.cn/Article/CJFDTOTAL-SHYY201911011.htm

    CAO M, WANG Q J. Influence of plasma homocysteine level change on atherosclerosis in H-type hypertension patients[J]. Laboratory Medicine, 2019, 34(11): 1007-1010. https://www.cnki.com.cn/Article/CJFDTOTAL-SHYY201911011.htm
    [9]
    徐志娜, 周建松, 古忆, 等. 血浆同型半胱氨酸与冠心病的相关性及其与冠心病传统危险因素的关系[J]. 贵州医科大学学报, 2016, 41(11): 1318-1321. https://www.cnki.com.cn/Article/CJFDTOTAL-GYYB201611018.htm

    XU Z N, ZHOU J S, GU Y, et al. Study on Correlation between HCY and Coronary Heart Disease and Traditional Risk Factors of Coronary Heart Disease[J]. Journal of Guizhou Medical University, 2016, 41(11): 1318-1321. https://www.cnki.com.cn/Article/CJFDTOTAL-GYYB201611018.htm
    [10]
    唐亮, 乐建华, 李赛帅, 等. 高血压患者血压变异性与靶器官损害的关系分析[J]. 中国实用医药, 2020, 15(6): 40-41. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSSA202006017.htm

    TANG L, LE J H, LI S S, et al. Relationship between blood pressure variability and target organ damage in patientswith hypertension[J]. China Practical Medicine, 2020, 15(6): 40-41. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSSA202006017.htm
    [11]
    陈海荣, 李名兰, 潘碧云, 等. 血浆同型半胱氨酸水平与高血压患者血压变异性的相关性分析[J]. 内科急危重症杂志, 2020, 26(4): 280-282, 324. https://www.cnki.com.cn/Article/CJFDTOTAL-NKJW202004006.htm

    CHEN H R, LI M L, PAN B Y, et al. Association between plasma homocysteine level and blood pressure variability in patients with hypertension[J]. Journal of Internal Intensive Medicine, 2020, 26(4): 280-282, 324. https://www.cnki.com.cn/Article/CJFDTOTAL-NKJW202004006.htm
    [12]
    徐菲菲, 刘咏梅, 房振宇, 等. 原发性肾小球肾炎患者血浆高同型半胱氨酸水平的变化及与钙磷乘积和血尿酸的相关性分析[J]. 现代生物医学进展, 2020, 20(3): 558-560, 548. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202003034.htm

    XU F F, LIU Y M, FANG Z Y, et al. Changes of Plasma Hcy in Patients with Primary Glomerulonephritis and Its Correlation with Calcium-phosphorus Product and Blood Uric Acid[J]. Progress in Modern Biomedicine, 2020, 20(3): 558-560, 548. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202003034.htm
    [13]
    孙炜炜, 刘婷, 邵泽伟, 等. 冠心病患者血清同型半胱氨酸与血脂指标的相关性研究[J]. 中国卫生标准管理, 2017, 8(13): 124-126. https://www.cnki.com.cn/Article/CJFDTOTAL-WSBZ201713069.htm

    SUN W W, LIU T, SHAO Z W, et al. The Correlation Research Between Serum Homocysteine and Blood Lipids in Patients With Coronary Diseas[J]. China Health Standard Management, 2017, 8(13): 124-126. https://www.cnki.com.cn/Article/CJFDTOTAL-WSBZ201713069.htm
    [14]
    陈礼萍. 冠心病患者血浆同型半胱氨酸水平与血压变异性的相关性分析[D]. 昆明: 昆明医科大学, 2020.

    CHEN L P. Correlation between plasma homocysteine level and blood pressure variability in patients with coronary heart disease[D]. Kunming: Kunming Medical University, 2020.
    [15]
    杨晓明, 王审. 长期大剂量服用阿托伐他汀对老年高血压合并冠心病的疗效和安全性评价[J]. 中华全科医学, 2018, 16(12): 2035-2038. doi: 10.16766/j.cnki.issn.1674-4152.000555

    YANG X M, WANG S. Efficacy and Safety of long term high-dose atorvastatin in elderly patients with hypertension complicated with coronary heart disease[J]. Chinese Journal of General Practice, 2018, 16(12): 2035-2038. doi: 10.16766/j.cnki.issn.1674-4152.000555
    [16]
    DHAR P, SHARMA V K, DAS S K, et al. Differential responses of autonomic function in sea level residents, acclimatized lowlanders at>3 500 m and Himalayan high altitude natives at >3 500 m: A cross-sectional study[J]. Respir Physiol Neurobiol, 2018. DOI: 10.1016/j.resp.2018.04.002.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(3)

    Article Metrics

    Article views (198) PDF downloads(6) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return